300 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
effective on April 1, 2024. J-codes simplify and streamline the billing and reimbursement processes for Medicare Part B treatments, allowing … ; the availability and extent of reimbursement of Regeneron’s Products from third-party payers, including private payer healthcare and insurance programs, health
8-K
EX-99.1
40zn8v1uucw8
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
EX-99.1
cva9l6bwire3wqt19d8n
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
5kk728cay6 j7
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
SC TO-T
EX-99
ucewmeuheui6
25 Aug 23
Third party tender offer statement
7:46am
8-K
EX-99.1
ynwra
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
EX-99.1
y2pk 8d82xl
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
8-K
EX-10.3
b2o3b8abfn62q
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
ac1pzv
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
dn9betx 18x4ni
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
6je9h cogxxrk88
20 Dec 22
Entry into a Material Definitive Agreement
4:01pm